This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of Jeffrey S. Cleaveland
Introduction
Jeffrey S. Cleaveland is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of peptide inhibitors. His work has implications for immunosuppression, antiviral therapies, and cancer treatment.
Latest Patents
One of his key patents is titled "Peptide inhibitors of nuclear protein translocation having nuclear." This patent discloses novel polypeptide inhibitors that facilitate the nuclear translocation of cytoplasmic proteins. The inhibitors consist of a signal sequence and at least two nuclear localization sequences. This innovation holds promise as a therapeutic agent in various medical applications.
Career Highlights
Jeffrey S. Cleaveland is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at the company allows him to further his research and development efforts in the field of biotechnology.
Collaborations
Throughout his career, Cleaveland has collaborated with esteemed colleagues, including Omar K. Haffar and James J. Blake. These collaborations have contributed to the advancement of his research and the successful development of innovative solutions in the industry.
Conclusion
Jeffrey S. Cleaveland's contributions to biotechnology through his patent and work at Bristol-Myers Squibb Company highlight his role as an influential inventor. His innovations continue to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile